MPLT
MapLight TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
MPLT vs peer average
59/100
MPLT vs. peer average (C vs. D)
Grade spread
B 1 · C 4 · D 5 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
IMTX is the first available peer comparator.
Immatics is closer in market cap and clinical-stage profile than large-cap biopharma peers, but the indication set differs, so peer read-through is limited.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
MPLT
MapLight Therapeutics
IMTX
Immatics
Grade
C
D
Momentum
96
11
Value
46
41
Sentiment
22
71
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs IMTX
MPLT / IMTX
Grade Position
In line
MPLT vs. peer average (C vs. D)
59/100
Momentum
96
MPLTValue
46
MPLTSentiment
22
IMTXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs MPLT
IMTX is the first peer returned for this comparison set.